N

Newcells Biotech

44 employees

Newcells Biotech are experts in the production of induced pluripotent stem cells.

Basic info

Industry

biotechnology research

Sectors

Medical Device
Biotechnology
Nephrotoxity Testing
DIKI
RPE
Drug Transport Studies
Sourcing samples for human disease cell lines
Proximal Tubule Model
Viral infection
ADMET
Drug Induced Kidney Injury (DIKI)
Supply of iPSC derived cells for drug development
Cellular reprogramming and differentiation
Pharmaceutical
Retinal Epithelial Model
Liver Sinusoid
Stem Cell Models
Induced pluripotent stem cells (iPSCs)
Health Care
Lung Epithelia
Therapeutics
Medical
Retinal Epithelia
Disease Modelling

Date founded

2014

Funding rounds raised

Total raised

$7.1M

from 2 investors over 2 rounds

N

Newcells Biotech raised $7.1M on February 24, 2021

Investors: The North East Fund Ltd.

N

Newcells Biotech raised $2.6M on July 4, 2018

Investors: NVM Private Equity LLP

FAQ